Showing results (1321-1330 of 2,331) with videos related to

Sort By:
Pageof 234
Clinical Drug Investigation|January 23, 2021
Effects of Sacubitril/Valsartan in Patients with High Arrhythmic Risk and an ICD: A Longitudinal StudyMatteo Casale, Michele Correale, Giulia Laterra, et al.
Clinical Drug Investigation|January 23, 2021
The CITIMERIVA Study: CITIcoline plus MEmantina plus RIVAstigmine in Older Patients Affected with Alzheimer's DiseaseAlberto Castagna, Ciro Manzo, Andrea Fabbo, et al.
Clinical Drug Investigation|October 2, 2019
Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical TrialArne W Scholtz, Ales Hahn, Bohdana Stefflova, et al.
Clinical Drug Investigation|August 12, 2019
Individualized Protease Inhibitor Monotherapy: The Role of Pharmacokinetics and Pharmacogenetics in an Aged and Heavily Treated HIV-Infected PatientElena López Aspiroz, Salvador Enrique Cabrera Figueroa, María Paz Valverde Merino, et al.
Clinical Drug Investigation|August 11, 2019
Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims DatabaseYoko Hirano, Yoichi Ii
Clinical Drug Investigation|April 2, 2011
Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective studySatoru Iwashima, Mituaki Kimura, Takamichi Ishikawa, et al.
Clinical Drug Investigation|June 2, 2011
Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro studyGeorge Shlieout, Andreas Koerner, Mario Maffert, et al.
Clinical Drug Investigation|June 2, 2011
Combination delapril/manidipine as antihypertensive therapy in high-risk patientsRoberto Fogari, Amedeo Mugellini, Maria Circelli, et al.
Clinical Drug Investigation|June 2, 2011
Bevacizumab plus interferon-α versus sunitinib for first-line treatment of renal cell carcinoma in Italy: a cost-minimization analysisRoberto Ravasio, Cinzia Ortega, Roberto Sabbatini, et al.
Clinical Drug Investigation|April 19, 2011
Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorderLeslie Citrome, Richard I G Holt, Daniel J Walker, et al.
Pageof 234